GSK Consumer Healthcare slips after weak Q4 earnings

MUMBAI, May 18:  Shares of GlaxoSmithKline (GSK) Consumer Healthcare fell over 5 per cent today after the company reported an 8.18 per cent decline in standalone net profit for the March quarter at Rs 180.68 crore.
Opening on a weak note, the stocks further slumped 5 per cent to Rs 5,792.
At NSE, shares of the firm fell 5.46 per cent to Rs 5,779.
The company had posted a net profit of Rs 196.78 crore for the corresponding period a year ago, GSK had said in a BSE filing yesterday.
Net sales during the period under review was Rs 1,052.83 crore, down 9.63 per cent from Rs 1,165.06 crore in the corresponding period last fiscal.
For the full fiscal, GSK’s standalone net profit rose 17.70 per cent to Rs 686.91 crore as against Rs 583.60 crore in 2014-15.
However, its net sales declined 0.72 per cent to Rs 4,106.61 crore in 2015-16 from Rs 4,136.44 crore a year ago. (PTI)